CNN — More than 1 in 9 seniors in the United States is living with Alzheimer’s disease, and the number of people affected is expected to double over the next…
Tag: Alzheimers
Alzheimer’s drug lecanemab receives accelerated FDA approval amid safety concerns
CNN — The US Food and Drug Administration granted accelerated approval Friday for the Alzheimer’s disease drug lecanemab, one of the first experimental dementia drugs to appear to slow the…
Report shares new details about death possibly linked to experimental Alzheimer’s drug
CNN — The death of a participant in a clinical trial of an antibody treatment for Alzheimer’s disease, which is now under consideration by the US Food and Drug Administration,…
FDA Approves, Leqembi, New Treatment for Early Alzheimer’s
The Food and Drug Administration on Friday approved a new Alzheimer’s drug that may modestly slow the pace of cognitive decline early in the disease, but also carries risks of…
Lecanemab: FDA decision on experimental Alzheimer’s drug expected this week
CNN — The US Food and Drug Administration could decide this week whether to grant accelerated approval to the experimental dementia drug lecanemab, according to Eisai and Biogen, the companies…
Congressional Investigation into Alzheimer’s Drug Aduhelm Faults the F.D.A. and Biogen
The F.D.A.’s own internal inquiry said there was “no evidence” its interactions with Biogen were “anything but appropriate,” given the data’s complexity and the importance of Alzheimer’s, but it issued…
Alzheimer’s And Corticobasal Degeneration Is Hurting My Family
My oldest sister, Abby, calls for the second time this morning. “Oh, Jannie!” she says, reverting to my baby-sister nickname. “It’s so great to hear your voice, finally! Are you…
Alzheimer’s APOE4 Genetic Risk Targeted in Promising Trial
In a bold attempt to stop the progress of some cases of Alzheimer’s disease, a group of researchers is trying something new — injecting a protective gene into patients’ brains.…
Alzheimer’s Drug May Benefit Some Patients, New Data Shows
Dr. Thambisetty said the two deaths add to questions about lecanemab’s safety issues “in real world clinical practice where patients are likely to be sicker and have multiple other medical…